Mpox virus: Difference between revisions

From IDWiki
m ()
No edit summary
Line 1: Line 1:
= Microbiology =
+
== Microbiology ==
   
 
* Monkeypox virus (MPXV) is in the genus ''Orthopoxvirus'' and family ''Poxviridae''
 
* Monkeypox virus (MPXV) is in the genus ''Orthopoxvirus'' and family ''Poxviridae''
   
= Epidemiology =
+
== Epidemiology ==
   
 
* Zoonotic disease endemic to west and central Africa
 
* Zoonotic disease endemic to west and central Africa
Line 12: Line 12:
 
* Human-to-human transmission possible, but less than smallpox
 
* Human-to-human transmission possible, but less than smallpox
   
= Clinical Presentation =
+
== Clinical Presentation ==
   
 
* Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy
 
* Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy
Line 19: Line 19:
 
* Mortality 1-10% (per WHO)
 
* Mortality 1-10% (per WHO)
   
= Management =
+
== Management ==
   
== Post-exposure prophylaxis ==
+
=== Post-exposure prophylaxis ===
   
 
* ??smallpox vaccine??
 
* ??smallpox vaccine??

Revision as of 07:17, 16 August 2019

Microbiology

  • Monkeypox virus (MPXV) is in the genus Orthopoxvirus and family Poxviridae

Epidemiology

  • Zoonotic disease endemic to west and central Africa
    • Hosts include non-human primates and prairie dogs, squirrels, and possibly other rodents
    • Endemic countries include DRC (most common), Liberia, Ivory Coast, Sierra Leone, Nigeria, Benin, Cameroon, Gabon, and South Sudan
  • Human infection is associated with animal trapping, hunting, and skinning, and other exposures to animals including bites, feces, urine, or respiratory droplets
    • Global outbreaks may happen with the global trafficking in exotic pets
  • Human-to-human transmission possible, but less than smallpox

Clinical Presentation

  • Clinically indistinguishible from smallpox, though may have much more pronounced lymphadenopathy
  • Incubation period about 12 days
  • Fever, rash, lymphadenopathy (cervical, submandibular, and sublingual)
  • Mortality 1-10% (per WHO)

Management

Post-exposure prophylaxis

  • ??smallpox vaccine??